Clinical study of PNV-5030
Latest Information Update: 26 Oct 2021
At a glance
- Drugs PNV-5030 (Primary)
- Indications Pain
- Focus Adverse reactions; First in man
- Sponsors ADial Pharmaceuticals
- 26 Oct 2021 New trial record
- 21 Oct 2021 According to an Adial Pharmaceutical media release, the company expects PNV-5030 to enter clinical trial in 2022.